The minimal effective dose of cis-9-cetylmyristoleate (CMO) in persons presenting with knee joint pain: a double-blind, randomized, placebo-controlled trial

Citation metadata

From: Medicine(Vol. 96, Issue 9)
Publisher: Lippincott Williams & Wilkins, WK Health
Document Type: Report

Document controls

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A494848021